EPA Registers MicroGuard Antimicrobial Alloys for Sale With Public Health Claims
Based on the results of extensive efficacy testing, the Environmental Protection Agency (EPA) has registered MicroGuard antimicrobial alloys for sale with public health claims. The registration acknowledges that products made of MicroGuard metals can kill harmful bacteria* responsible for causing millions of infections each year. When used as directed, MicroGuard touch surfaces are designed to kill greater than 99.9 percent of disease causing bacteria* including methicillin-resistant Staphylococcus aureus (MRSA), a superbug responsible for over 94,000 hospital-acquired infections each year.
Products made of MicroGuard antibacterial materials are the first registered products available for immediate sale. MicroGuard materials and component hardware are approved for touch surfaces in hospitals, schools, commercial buildings, and homes. Some of the EPA approved applications include: hand and stair railing, door hardware, hospital bedrails, medical IV stands, medical carts and countertops
Designed to replace stainless steel with the added benefit of killing infectious bacteria*, MicroGuard alloys are both fingerprint and stain resistant. PMX Industries will be releasing additional products made of MicroGuard materials as market needs are identified.
“While MicroGuard surfaces are not a substitute for good cleaning and disinfection practices, MicroGuard may be an ideal supplement to a multi-faceted approach to reduce hospital-acquired infections,” said Tom Bobish, vice president of sales and marketing at PMX. “Unlike antimicrobial coatings which cannot claim to kill infectious bacteria, the antimicrobial properties of MicroGuard will not wear away or be rubbed off. The antibacterial efficacy of MicroGuard remains effective for the life of the product.”
*Staphylococcus aureus, Enterobacter aerogenes, Methicillin-Resistant Staphylococcus aureus (MRSA), Escherichia coli 0157:H7 and Pseudomonas aeruginosa.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
